Multicentric trial on the effectiveness of shortened post-infusion scalp cooling times in the prevention of docetaxel-induced hair loss.
Completed
- Conditions
- chemotherapy-induced hair loss(Dutch: haarverlies door chemotherapie)
- Registration Number
- NL-OMON27012
- Lead Sponsor
- Comprehensive Cancer Center South (IKZ), Eindhoven, The Netherlands
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1. Intravenous administered docetaxel-regimens at 3-weekly intervals;
2. Age 18 years or more;
Exclusion Criteria
1. TAC chemotherapy;
2. Sequential docetaxel following FEC or AC chemotherapy;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients not in need of wig or head cover.
- Secondary Outcome Measures
Name Time Method 1. Impact of prior chemotherapy or hormonal therapy and liver or kidney function disorders on the result of scalp cooling;<br /><br>2. The amount and pattern of hair loss;<br /><br>3. Quality of hair during scalp cooling;<br /> <br>4. Reasons to stop scalp cooling.